Exchange: NYSE·Updated 07:30 PM EDT

PEN News

News
all
press releases
Reasons to Retain Penumbra Stock in Your Portfolio for Now
PEN's portfolio expansion and international growth support momentum, while rising costs, FX exposure and margin pressure remain key risks.
Zacks
More News
TFX vs. PEN: Which Stock Is the Better Value Option?
TFX vs. PEN: Which Stock Is the Better Value Option?
Zacks
TFX or PEN: Which Is the Better Value Stock Right Now?
TFX vs. PEN: Which Stock Is the Better Value Option?
Zacks
TFX vs. PEN: Which Stock Is the Better Value Option?
TFX vs. PEN: Which Stock Is the Better Value Option?
Zacks
Is ANGO a Buy as Med Tech Growth Battles Persistent Margin Pressure?
AngioDynamics' Med Tech growth and reimbursement gains strengthen its outlook, but tariffs, rising costs and execution risks keep the buy case uncertain.
Zacks
Penumbra, Inc. Reports Second Quarter 2026 Financial Results
Penumbra, Inc. Reports Second Quarter 2026 Financial Results Penumbra, Inc. Reports Second Quarter 2026 Financial Results PR Newswire ALAMEDA, Calif., July 30, 2026 ALAMEDA, Calif., July 30, 2026 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN), the world's leadingthrombectomy company, today reported...
PR Newswire
THUNDER Study Demonstrates Penumbra's THUNDERBOLT is Safe and Effective for Stroke Care
THUNDER Study Demonstrates Penumbra's THUNDERBOLT is Safe and Effective for Stroke Care THUNDER Study Demonstrates Penumbra's THUNDERBOLT is Safe and Effective for Stroke Care PR Newswire ALAMEDA, Calif., July 22, 2026 First and only CAVT device for stroke demonstrated high revascularization rates...
PR Newswire
IQV vs. PEN: Which Stock Is the Better Value Option?
IQV vs. PEN: Which Stock Is the Better Value Option?
Zacks
First Patient Enrolled in Penumbra's FORWARD Study Evaluating Mechanical Thrombectomy and Computer Assisted Vacuum Thrombectomy for Distal Acute Ischemic Stroke
First Patient Enrolled in Penumbra's FORWARD Study Evaluating Mechanical Thrombectomy and Computer Assisted Vacuum Thrombectomy for Distal Acute Ischemic Stroke First Patient Enrolled in Penumbra's FORWARD Study Evaluating Mechanical Thrombectomy and Computer Assisted Vacuum Thrombectomy for Distal...
PR Newswire
GMED vs. PEN: Which Stock Should Value Investors Buy Now?
GMED vs. PEN: Which Stock Is the Better Value Option?
Zacks

Advertisement|Remove ads.